Skip to main content

Peer Review reports

From: Safety and efficacy of sirolimus in recurrent intravenous leiomyomatosis, pulmonary benign metastatic leiomyomatosis, and leiomyomatosis peritonealis disseminata: a pilot study

Original Submission
12 Oct 2023 Submitted Original manuscript
9 Dec 2023 Reviewed Reviewer Report
17 Dec 2023 Reviewed Reviewer Report
13 Jan 2024 Reviewed Reviewer Report - Victor C. Kok
4 Feb 2024 Author responded Author comments - Guorui Zhang
Resubmission - Version 2
4 Feb 2024 Submitted Manuscript version 2
5 Feb 2024 Reviewed Reviewer Report
16 Feb 2024 Reviewed Reviewer Report - Victor C. Kok
16 Feb 2024 Reviewed Reviewer Report
3 Mar 2024 Author responded Author comments - Guorui Zhang
Resubmission - Version 3
3 Mar 2024 Submitted Manuscript version 3
Publishing
6 Mar 2024 Editorially accepted
13 Mar 2024 Article published 10.1186/s12916-024-03344-9

You can find further information about peer review here.

Back to article page